Upper Extremity Problem

0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

MicroTransponder
MicroTransponderTX - Austin
1 program
Vivistim SystemN/A1 trial
Active Trials
NCT05301140Recruiting1,000Est. Dec 2028

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
2027
2028
MicroTransponderVivistim System

Clinical Trials (1)

Total enrollment: 1,000 patients across 1 trials

Vivistim Registry for Paired VNS Therapy (GRASP)

Start: Mar 2023Est. completion: Dec 20281,000 patients
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 1,000 patients
1 companies competing in this space